» Articles » PMID: 18364586

Clinical Importance of Impedance Measurements

Overview
Specialty Gastroenterology
Date 2008 Mar 28
PMID 18364586
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Because impedance changes have been shown to be a sensitive and reliable means to detect fluid or gas movement within the esophagus, numerous studies worldwide have addressed the potential for impedance determinations to provide a sensitive measure of either esophageal transit function or the presence and extent of gastroesophageal reflux. Using a catheter with multiple impedance measuring sites [multichannel intraluminal impedance (MII)] allows the opportunity to track fluid movement within the esophagus.

Aim: To review the clinical importance of impedance measurements.

Conclusions: Ambulatory MII-pH monitoring is a valuable tool in the assessment of reflux because it identifies not only acid reflux but overcomes the deficiency of simple pH monitoring by showing all reflux types, both acid and nonacid. It is our belief that MII-pH testing on proton pump inhibitor therapy has become the new "gold standard" for detection of reflux and for clarifying its relationship to symptoms.

Citing Articles

Advantage of multichannel intraluminal impedance in the diagnosis of aerophagia: a case report.

Tanaka A, Fujii T, Katami H, Shimono R BMC Pediatr. 2024; 24(1):602.

PMID: 39333957 PMC: 11437822. DOI: 10.1186/s12887-024-05081-7.


Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications?.

Ward M, Dunst C, Glasgow M, Teitelbaum E, Abdelmoaty W, Reavis K J Gastrointest Surg. 2019; 23(7):1301-1308.

PMID: 30859425 DOI: 10.1007/s11605-019-04148-6.


Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis.

Ang D, Zheng Q, Shi L, Tack J United European Gastroenterol J. 2018; 6(9):1294-1306.

PMID: 30386602 PMC: 6206531. DOI: 10.1177/2050640618772787.


Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.

Ward M, Dunst C, Teitelbaum E, Halpin V, Reavis K, Swanstrom L Surg Endosc. 2017; 32(2):889-894.

PMID: 28779252 DOI: 10.1007/s00464-017-5759-7.


Surgical Treatment of Gastroesophageal Reflux Disease.

Schlottmann F, Herbella F, Allaix M, Rebecchi F, Patti M World J Surg. 2017; 41(7):1685-1690.

PMID: 28258448 DOI: 10.1007/s00268-017-3955-1.